IRIS
COLUCCIA, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.437
EU - Europa 1.223
AS - Asia 894
OC - Oceania 4
SA - Sud America 2
Totale 7.560
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.427
CN - Cina 638
SE - Svezia 391
SG - Singapore 200
UA - Ucraina 197
IT - Italia 196
DE - Germania 162
FI - Finlandia 132
GB - Regno Unito 67
IN - India 28
BE - Belgio 17
IE - Irlanda 15
FR - Francia 13
IR - Iran 12
CZ - Repubblica Ceca 11
CA - Canada 10
VN - Vietnam 10
RU - Federazione Russa 9
AT - Austria 3
AU - Australia 3
LT - Lituania 3
HK - Hong Kong 2
RO - Romania 2
SA - Arabia Saudita 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CL - Cile 1
EC - Ecuador 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
SI - Slovenia 1
Totale 7.560
Salva come PNG Salva come JPEG
Città #
Fairfield 634
Chandler 602
Woodbridge 576
Jacksonville 461
Houston 365
Nyköping 327
Ashburn 324
Seattle 267
Ann Arbor 255
Cambridge 244
Wilmington 211
Singapore 146
Nanjing 141
Lawrence 128
Roxbury 128
Bari 126
Beijing 118
New York 109
Boardman 87
Des Moines 84
Princeton 57
Inglewood 55
Nanchang 42
Hebei 39
Helsinki 34
San Diego 32
Shenyang 32
Jiaxing 31
Santa Clara 30
Dearborn 29
Brooklyn 24
Pune 21
Los Angeles 19
Tianjin 19
Brussels 17
Guangzhou 17
Dublin 15
Ardabil 12
Changsha 12
Shanghai 12
Brno 11
Auburn Hills 10
Dong Ket 10
Kunming 10
Leawood 10
Ningbo 9
Washington 9
Jinan 8
San Francisco 8
San Mateo 8
Wuhan 8
Augusta 7
London 7
Redwood City 7
Toronto 7
Wuxi 7
Jinhua 6
Norwalk 6
Paris 6
Taizhou 6
Zhengzhou 6
Hefei 5
Milan 5
Mumbai 5
Yiwu 5
Hangzhou 4
Baotou 3
Lanzhou 3
Monmouth Junction 3
Munich 3
Santa Marinella 3
Sassari 3
Shenzhen 3
Terlizzi 3
Vienna 3
Berlin 2
Brescia 2
Calci 2
Dongyang 2
Fuzhou 2
Grafing 2
Grottaglie 2
Hong Kong 2
Hounslow 2
Kilburn 2
Melbourne 2
Quanzhou 2
Riyadh 2
Acton 1
Bacoli 1
Bandar Seri Begawan 1
Baoding 1
Bucharest 1
Chiswick 1
Chongqing 1
Christchurch 1
Dalian 1
Edinburgh 1
Falls Church 1
Freiberg 1
Totale 6.137
Salva come PNG Salva come JPEG
Nome #
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 140
Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature 135
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 127
Mutagenic activity of some platinum complexes: chemical properties and biological activity 122
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 120
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 115
Effect of chirality in platinum drugs 109
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 108
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 108
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells 107
Mutagenic activity of some platinum complexes with monodentate and bidentate amines 105
null 104
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 101
Efficacy of 5FU combined to Na[trans-RuCl4(DMSO)Im], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline, and MCa mammary carcinoma 96
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 95
Trans-Platinum Compounds in Cancer Therapy: A largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs 94
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 92
Ruthenium-sulfoxide complexes with a specific antimetastatic activity 90
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 90
null 90
null 88
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 85
Biologic activity of platiunum complexes with proflavine 82
Endothelial cells in the bone marrow of patients with multiple myeloma 82
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 82
Platinum(II) based anticancer agents with a trans geometry 81
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 81
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 80
In vitro cisplatin effects on phagocyte functions 78
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 77
Effect of isomerism at non-leaving ligands in platinum anticancer drugs 77
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 75
Current Status of trans-Platinum Compounds in Cancer Therapy 75
Trans-Platinum Complexes in Cancer Therapy 74
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 74
Antitumour platinum-iminoether complexes 72
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 72
Antitumor active trans-platinum compounds 72
Antitumour platinum iminoether complexes 71
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 71
A preclinical overview on gold(III) compounds in the forefront of the targeted anticancer therapy. 69
Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate ring. 68
null 68
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 68
null 67
null 66
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 66
null 65
null 65
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 64
Antitumour platinum iminoether complexes 64
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 63
Salivary up-regulation of human polymorphonuclear leucocyte chemotaxis and adhesion-molecule expression 63
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 62
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 61
A Framework for Biological Data Normalization, Interoperability, and Mining for Cancer Microenvironment Analysis 61
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 60
Antitumor trans iminoether platinum di- and oligonucleotide adducts studied by NMR. 60
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 60
Antitumour ruthenium(II)-dimethylsulfoxide complexes 60
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 59
Effect of antitumor platinum compounds with trans geometry on the induction of cytotoxicity and cell cycle modifications 56
Bone Marrow Fibroblasts and Multiple Myeloma Progression 56
Anttitumor activity of trans-platinum species 56
Antitumor activity of trans platinum complexes 56
null 55
null 55
CITOTOSSICITA' IN VITRO DI ALCUNI MATERIALI DENTALI 53
null 53
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 52
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 52
null 52
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 51
null 51
Salivary up-regulation of PMN chemotaxis and adhesion molecules expression 49
Na[trans-RuCl4(DMSO)Im]2DMSO: antimetastatic ruthenium 48
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 48
Interaction of RuCl2 (dimethylsulphoxide)4 isomers with DNA 48
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 48
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 48
Ulteriori contributi allo studio dell'interazione cisplatino-DNA 46
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 46
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 45
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 45
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 45
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 44
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 44
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 43
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 42
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 42
Complessi antitumorali di platino a geometria trans 40
Trans platinum complexes in cancer therapy: a largely unexplored strategy of identifying novel antitumour platinum drugs 39
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 39
DNA modifications by antitumor trans-[PtCl2(E-iminoether)2] 39
Inhibition of matrix metallo proteinase activity by novel platinum complexes with bisphosphonate analogues 38
Response of MCa mammary carcinoma to cisplatin and to Na(trans- Rucl4(DMSO)Im): Selective inhibition of spontaneous lung metastases by the ruthenium complex. 38
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 37
Mutagenic activity of some paltinum complexes: Chemical properties and biological activity 36
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 35
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 34
Totale 6.840
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.079 0 0 0 0 160 92 179 119 181 93 228 27
2020/20211.276 150 49 151 48 137 65 75 90 156 177 123 55
2021/2022787 21 121 1 30 32 33 32 35 44 49 156 233
2022/20231.524 217 144 123 145 196 202 6 194 233 11 22 31
2023/2024565 40 87 25 27 69 183 4 35 12 10 1 72
2024/2025458 138 30 183 64 43 0 0 0 0 0 0 0
Totale 7.860